Trial NCT05411107

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2022-04698
Secondary IDs: NCI-2022-04698 NCI21-08-01 NWU21-08-01 P30CA060553 UG1CA242643

Last trial update was posted on 2024-04-19

MeSH Interventions

Iloprost

MeSH Conditions

Carcinoma Lung Diseases, Obstructive Lung Neoplasms Pulmonary Disease, Chronic Obstructive

Other Conditions

Bronchial Epithelial Dysplasia Chronic Obstructive Pulmonary Disease Lung Carcinoma Stage I Lung Cancer AJCC v8 Stage II Lung Cancer AJCC v8 Tobacco-Related Carcinoma

Stopping Reasons

Agent is not available

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
1 annotator(s) decided on categories
# Outdated Drug otherDrug toxicity/
tolerability
Drug supply/
availability
Drug withdrawn by regulatorFutility/
No clinical benefit
Funding issuesRecruitment/
Accrual/
Enrollment
Investigator leftOtherCOVID-19 pandemic
1-DODTDSDWFUFRPIOC19

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID